Lv3
238 积分 2023-04-25 加入
Assessing Outcomes Emerging After Conversion to Regular Approval for Cancer Drug Indications Granted Accelerated Approval, 1992-2021
11个月前
已完结
Oncology Accelerated Approval Confirmatory Trials: When a Failed Trial Is Not a Failed Drug
11个月前
已完结
Exploring the next generation of antibody–drug conjugates
11个月前
已完结
Increasing FDA-accelerated approval of single-arm trials in oncology (1992 to 2020)
11个月前
已完结
A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions
1年前
已完结
Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials
1年前
已完结
Assessing Outcomes Emerging After Conversion to Regular Approval for Cancer Drug Indications Granted Accelerated Approval, 1992-2021
1年前
已完结
Assessing Outcomes Emerging After Conversion to Regular Approval for Cancer Drug Indications Granted Accelerated Approval, 1992-2021
1年前
已完结
A meta-analysis of the impact of pharmacist interventions on clinical outcomes in patients with type-2 diabetes
1年前
已完结
皖公网安备34019202002308
